Outcome predictors of high-energy transurethral microwave thermotherapy

Techniques in Urology

Volumn 6, Issue 4, 2000, Pages 262-266

  Bursa, B ^a   Wammack, R ^a   Djavan, B ^a   Planz, B ^a   Waldert, M ^a   Dobronski, P ^a   Stoklosa, A ^a   Borkowski, A ^a   Jakubcky, T ^a   Marberger, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Benign prostatic; Histopathology; Predictive value; Prostate specific antigen; Transurethral microwave thermotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TREATMENT OUTCOME;

HUMANS; HYPERTHERMIA, INDUCED; MALE; MICROWAVES; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; TREATMENT OUTCOME; URETHRA;

EID: 0034486841     PISSN: 10793259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Transurethral microwave thermotherapy: What role should it play versus medical management in the treatment of BPH?
2. Transurethral prostatectomy: A long-term follow-up study of 166 patients over 80 years of age
3. Transurethral prostatectomy: Immediate and postoperative complications. A co-operative study of 13 participating institutions evaluating 3885 patients
4. Results of high-energy TUMT in patients categorized according to the American Society of Anesthesiologists operative risk classification
5. Temporary intraurethral prostatic bridge catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy
6. How to select patients for high energy transurethral microwave thermotherapy?
7. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus α-blocker treatment of patients with benign prostatic hyperplasia
8. Neoadjuvant and adjuvant α-blockade improves early results of high- energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: A randomized, prospective clinical trial
9. The clinical development of a 5-alpha-reductase inhibitor, finasteride
10. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
11. Screening for prostatic carcinoma with PSA
12. The promise of new serum markers for prostate cancer
13. Combination and multivariate analysis of PSA-based parameters for prostate cancer
14. A killikrein-like serine protease in prostatic fluid cleaves the predominant seminal fluid protein
15. Effect of digital rectal examination on serum complexed and free prostate specific antigen and percentage of free prostate specific antigen
16. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
17. Total and transition zone volume and age: How do they affect the utility of PSA-based parameters for early prostate cancer detection?
18. Elevated serum PSA due to acute bacterial prostatitis
19. PSA and prostatitis I: Effect of prostatitis on serum PSA in the human and non-human primate
20. Effects of rectal examination, prostatic massage, ultrasonography, and needle biopsy on serum PSA levels
21. The effect of digital rectal examination on serum levels of PSA
22. Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction
23. High temperature thermotherapy of the prostate creates TUR defect without anesthesia
24. Extent of thermal cell death correlated to accurate interstitial temperatures of ten pathologic prostate specimens using urologix T3 microwave transurethral thermal therapy unit
25. Local microwave hyperthermia of benign prostatic hyperplasia
26. Transurethral hyperthermia for benign prostatic hyperplasia: Preliminary clinical results
27. Transurethral hyperthermia for benign prostatic hypertrophy
28. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study
29. Pretreatment prostate specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy
30. Responders and nonresponders to transurethral microwave thermotherapy: A multicenter retrospective analysis
31. The predictive value of baseline parameters in the treatment of benign prostatic hyperplasia using high-energy transurethral microwave thermotherapy
32. Transrectal ultrasonography to predict the clinical outcome of transurethral microwave thermotherapy in patients with benign prostatic hyperplasia
33. Transurethral microwave thermotherapy for benign prostatic hyperplasia: Relation between clinical response and prostate histology
34. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
35. Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia